CAITLIN KEEN: Open Payments
NPI 1114580073 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,582 in 173 payments from 18 companies in 2025. Trend: 2023 $2,904 · 2024 $3,602 · 2025 $3,582
Food & beverage: $3,582
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $445 |
| Otsuka America Pharmaceutical, Inc. | 19 | $433 |
| Lundbeck LLC | 19 | $401 |
| Neurocrine BioSciences, Inc. | 16 | $397 |
| Alkermes, Inc. | 22 | $346 |
| ABBVIE INC. | 17 | $316 |
| Axsome Therapeutics, Inc. | 13 | $231 |
| Teva Pharmaceuticals USA, Inc. | 10 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $186 |
| Corium, LLC | 7 | $167 |
Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, ARISTADA, AUSTEDO XR, Auvelity, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
